Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

US Patent 9655954 · Granted May 23, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for activating signaling through the CB1 cannabinoid re2025
Spinal screw insertion devices and methods2025
Biomaterial delivery device, and related systems and methods2025
Use of polyvinylacetate polymers or copolymers to increase the viscosity of the 2024
Compositions and methods for activating signaling through the CB1 cannabinoid re2024
Methods of treating acid sphingomyelinase deficiency2024
Materials and methods for identifying spinal muscular atrophy carriers2022
Compositions and methods for inhibiting expression of the ALAS1 gene2021
Therapeutic acid ceramidase compositions and methods of making and using them2021
Marker for acid sphingomyelinase disorders and uses thereof2021
Compositions and methods for inhibiting expression of the ALAS1 gene2019
Ceramidase and cell differentiation2019